{"created":"2023-05-15T14:36:50.742200+00:00","id":47472,"links":{},"metadata":{"_buckets":{"deposit":"e25aa5d0-64b0-4951-b51e-7021a1f669ea"},"_deposit":{"created_by":1,"id":"47472","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"47472"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00047472","sets":["1"]},"author_link":["475587","475595","475588","475591","475593","475592","475590","475586","475594","475589"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2015-02","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"6","bibliographicPageEnd":"540","bibliographicPageStart":"536","bibliographicVolumeNumber":"42","bibliographic_titles":[{"bibliographic_title":"Nuclear medicine and biology"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"A specific diagnosis for melanoma is strongly desired because malignant melanoma has poor prognosis. In a previous study, although radioiodine-125-labeled 4-hydroxyphenyl-L-cysteine ((125)I-L-PC) was found to have good substrate affinity for tyrosinase enzyme in the melanin metabolic pathway, (123/131)I-L-PC had insufficient substrate affinity for tyrosinase to diagnose melanoma. In this study, we synthesized 4-hydroxyphenylcysteamine (4-PCA) and developed a novel radioiodine-125-labeled 4-hydroxyphenylcysteamine ((125)I-PCA) to increase affinity for the melanin biosynthesis pathway.","subitem_description_type":"Abstract"}]},"item_8_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Elsevier"}]},"item_8_relation_13":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"25744361","subitem_relation_type_select":"PMID"}}]},"item_8_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1016/j.nucmedbio.2015.02.004","subitem_relation_type_select":"DOI"}}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0969-8051","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Kobayashi, Masato"}],"nameIdentifiers":[{"nameIdentifier":"475586","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Nishii, Ryuichi"}],"nameIdentifiers":[{"nameIdentifier":"475587","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Shikano, Naoto"}],"nameIdentifiers":[{"nameIdentifier":"475588","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"G, Flores Leo"}],"nameIdentifiers":[{"nameIdentifier":"475589","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Mizutani, Asuka"}],"nameIdentifiers":[{"nameIdentifier":"475590","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ogai, Kazuhiro"}],"nameIdentifiers":[{"nameIdentifier":"475591","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Sugama, Jyunko"}],"nameIdentifiers":[{"nameIdentifier":"475592","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Nagamachi, Shigeki"}],"nameIdentifiers":[{"nameIdentifier":"475593","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kawai, Keiichi"}],"nameIdentifiers":[{"nameIdentifier":"475594","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"西井 龍一","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"475595","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Development of radioiodine-labeled 4-hydroxyphenylcysteamine for specific diagnosis of malignant melanoma.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Development of radioiodine-labeled 4-hydroxyphenylcysteamine for specific diagnosis of malignant melanoma."}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2016-08-10"},"publish_date":"2016-08-10","publish_status":"0","recid":"47472","relation_version_is_last":true,"title":["Development of radioiodine-labeled 4-hydroxyphenylcysteamine for specific diagnosis of malignant melanoma."],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T23:39:24.699877+00:00"}